South Korea
# |
Name |
EBITDA |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 1.30 B
|
Dec. 31, 2023 | USD 745.69 | 1.15% |
|
South Korea |
|
2 |
USD 720.20 M
|
Dec. 31, 2023 | USD 119.86 | -2.20% |
|
South Korea |
|
3 |
USD 248.32 M
|
Dec. 31, 2023 | USD 159.35 | -4.24% |
|
South Korea |
|
4 |
USD 220.89 M
|
Dec. 31, 2023 | USD 56.39 | -4.53% |
|
South Korea |
|
5 |
USD 207.62 M
|
Dec. 31, 2023 | USD 13.69 | -2.57% |
|
South Korea |
|
6 |
USD 129.37 M
|
Dec. 31, 2023 | USD 23.36 | -2.28% |
|
South Korea |
|
7 |
USD 126.65 M
|
Dec. 31, 2023 | USD 89.76 | -4.42% |
|
South Korea |
|
8 |
USD 108.57 M
|
Dec. 31, 2023 | USD 65.38 | -0.04% |
|
South Korea |
|
9 |
USD 97.87 M
|
Dec. 31, 2023 | USD 83.97 | -5.00% |
|
South Korea |
|
10 |
USD 84.67 M
|
Dec. 31, 2023 | USD 6.82 | -1.91% |
|
South Korea |
|
11 |
USD 84.33 M
|
Dec. 31, 2023 | USD 88.80 | -5.65% |
|
South Korea |
|
12 |
USD 68.52 M
|
Dec. 31, 2023 | USD 15.49 | -2.92% |
|
South Korea |
|
13 |
USD 68.11 M
|
Dec. 31, 2023 | USD 9.85 | -4.50% |
|
South Korea |
|
14 |
USD 64.41 M
|
Dec. 31, 2023 | USD 12.66 | -2.66% |
|
South Korea |
|
15 |
USD 62.96 M
|
Dec. 31, 2023 | USD 18.22 | -3.57% |
|
South Korea |
|
16 |
USD 56.08 M
|
Dec. 31, 2023 | USD 9.61 | -3.70% |
|
South Korea |
|
17 |
USD 51.88 M
|
Dec. 31, 2023 | USD 5.23 | -2.06% |
|
South Korea |
|
18 |
USD 51.79 M
|
Dec. 31, 2023 | USD 3.69 | -1.06% |
|
South Korea |
|
19 |
USD 51.67 M
|
Dec. 31, 2023 | USD 15.77 | -2.26% |
|
South Korea |
|
20 |
USD 47.83 M
|
Dec. 31, 2023 | USD 31.05 | -1.12% |
|
South Korea |
|
21 |
USD 41.64 M
|
Dec. 31, 2023 | USD 34.59 | -4.65% |
|
South Korea |
|
22 |
USD 40.31 M
|
Dec. 31, 2023 | USD 54.68 | -7.62% |
|
South Korea |
|
23 |
USD 37.43 M
|
Dec. 31, 2023 | USD 4.07 | -1.95% |
|
South Korea |
|
24 |
USD 36.48 M
|
Dec. 31, 2023 | USD 9.80 | -1.72% |
|
South Korea |
|
25 |
USD 35.83 M
|
Dec. 31, 2023 | USD 33.57 | -2.13% |
|
South Korea |
|
26 |
USD 33.99 M
|
Dec. 31, 2023 | USD 16.51 | 0.47% |
|
South Korea |
|
27 |
USD 33.40 M
|
Dec. 31, 2023 | USD 32.21 | -3.61% |
|
South Korea |
|
28 |
USD 31.84 M
|
Dec. 31, 2023 | USD 7.90 | -1.67% |
|
South Korea |
|
29 |
USD 30.88 M
|
Dec. 31, 2023 | USD 11.00 | -3.03% |
|
South Korea |
|
30 |
USD 28.11 M
|
Dec. 31, 2023 | USD 11.62 | -0.90% |
|
South Korea |
|
31 |
USD 26.93 M
|
Dec. 31, 2023 | USD 7.87 | -2.10% |
|
South Korea |
|
32 |
USD 25.11 M
|
Dec. 31, 2023 | USD 77.77 | -3.69% |
|
South Korea |
|
33 |
USD 23.38 M
|
Dec. 31, 2023 | USD 11.86 | -0.20% |
|
South Korea |
|
34 |
USD 18.47 M
|
Dec. 31, 2023 | USD 7.21 | -0.62% |
|
South Korea |
|
35 |
USD 17.17 M
|
Dec. 31, 2023 | USD 4.14 | -7.03% |
|
South Korea |
|
36 |
USD 11.74 M
|
Dec. 31, 2023 | USD 9.81 | -0.42% |
|
South Korea |
|
37 |
USD 11.61 M
|
Dec. 31, 2023 | USD 7.33 | -4.07% |
|
South Korea |
|
38 |
USD 10.68 M
|
Dec. 31, 2023 | USD 3.22 | 0.07% |
|
South Korea |
|
39 |
USD 10.29 M
|
Dec. 31, 2023 | USD 15.36 | -2.10% |
|
South Korea |
|
40 |
USD 10.27 M
|
Dec. 31, 2023 | USD 2.87 | -2.35% |
|
South Korea |
|
41 |
USD 8.28 M
|
Dec. 31, 2023 | USD 1.89 | -1.74% |
|
South Korea |
|
42 |
USD 7.94 M
|
Dec. 31, 2023 | USD 8.58 | -5.12% |
|
South Korea |
|
43 |
USD 7.91 M
|
Dec. 31, 2023 | USD 11.53 | -7.22% |
|
South Korea |
|
44 |
USD 6.92 M
|
Dec. 31, 2023 | USD 8.44 | -2.89% |
|
South Korea |
|
45 |
USD 6.48 M
|
Dec. 31, 2023 | USD 5.00 | -8.15% |
|
South Korea |
|
46 |
USD 5.88 M
|
Dec. 31, 2023 | USD 1.37 | -0.64% |
|
South Korea |
|
47 |
USD 4.30 M
|
Dec. 31, 2023 | USD 1.18 | -3.42% |
|
South Korea |
|
48 |
USD 3.73 M
|
Dec. 31, 2023 | USD 3.01 | -3.95% |
|
South Korea |
|
49 |
USD 3.48 M
|
Dec. 31, 2023 | USD 1.12 | -3.94% |
|
South Korea |
|
50 |
USD 1.62 M
|
Dec. 31, 2023 | USD 25.27 | 1.91% |
|
South Korea |
The Healthcare company in South Korea with the highest EBITDA is Samsung Biologics Co.,Ltd. (KSE: 207940.KS) at USD 1.30 B.
The Healthcare company in South Korea with the lowest EBITDA is SD BioSensor, Inc (KSE: 137310.KS) at USD -192.66 M.
The top 10 Healthcare companies in South Korea by EBITDA are Samsung Biologics Co.,Ltd., Celltrion, Inc., Hanmi Pharm. Co., Ltd., Chong Kun Dang Pharmaceutical Corp., Daewoong Co., Ltd., Huons Global Co., Ltd., Daewoong pharmaceutical Co.,Ltd, Dong-A Socio Holdings Co., Ltd., Yuhan Corporation and Boryung Corporation.
The bottom 10 Healthcare companies in South Korea by EBITDA are SD BioSensor, Inc, GeneOne Life Science, Inc., Helixmith Co., Ltd, Aprogen pharmaceuticals,Inc., CrystalGenomics, Inc., Genexine, Inc., EOFLOW Co.,Ltd., Shin Poong Pharm.Co.,Ltd., MedPacto, Inc. and Bukwang Pharmaceutical Co., Ltd..